VP, Business Development and Licensing

Recursion•New York, NY

4d•$336,380 - $404,140•Hybrid

About The Position

Recursion is at the forefront of reimagining drug discovery, building an AI-native platform spanning biology, chemistry, and clinical development. This role will lead business development and licensing activities for Recursion's portfolio of first-in-class and best-in-class molecules. The individual will collaborate with internal asset leadership teams to identify licensing and co-development opportunities, conduct due diligence, and negotiate transactions. This position requires daily interaction with colleagues across various departments including Biology, Chemistry, Clinical Development, Safety, CMC, Data Science, Legal, and Finance to ensure alignment and efficient execution.

Requirements

BS/BA in life sciences (biology, chemistry, pharmacy, medical)
12-15+ years of experience in the biotechnology or pharmaceutical industry, with a focus on oncology and I&I
7+ years of direct business development and licensing experience with a strong track record of success in both buy-side and sell-side transactions
Strong network of senior relationships across biotechnology and large pharma
Deep knowledge of the drug development process from early discovery through clinical development and commercialization
Track record of leading complex, multi-stakeholder negotiations and closing high-value transactions
Demonstrated ability to manage multiple complex projects efficiently with a high degree of independence
Exceptional cross-functional collaboration skills and ability to communicate complex technical and commercial concepts to diverse audiences
Demonstrated interest in AI-enabled drug discovery space

Nice To Haves

Advanced degree (JD, MBA, PhD, PharmD) strongly preferred

Responsibilities

Initiate and build enduring relationships with senior business development and licensing counterparts at pharma and biotech organizations
Identify value-maximizing development and commercialization partners for Recursion’s existing clinical and preclinical assets
Partner with search and evaluation teams and cross-functional department leads to identify, prioritize, and diligence in-licensing and asset acquisition opportunities in Recursion’s key therapeutic areas (oncology, I&I)
Structure, negotiate, and execute a diverse array of agreements (licensing, acquisition, co-development/co-commercialization, spin-out) that align with Recursion's strategic objectives and values
Consolidate industry-wide feedback and advise internal teams on critical data-package deliverables
Represent Recursion's platform and acquisition strategy to senior scientific and business leaders across the industry